Nothing would undermine delivery of successful COVID-19 (coronavirus) vaccines and therapeutic treatments faster than the emergence of fake vaccines.  Health development and financing institutions already have their work cut out to raise public awareness and acceptance of these potential pandemic ending-solutions. The proliferation of falsified versions in marketplaces around the world would make the job even harder. The likely diversion of these highly prized commodities away from priority or underserved recipients would also be tragic. COVID-19 vaccines and therapeutics could be the catalyst to step up efforts around medicine traceability, but supply chains need to make fast progress. 

Continue reading →